Abstract

Background and Aims: The clinical presentations of pediatric patients infected with COVID-19 vary from mild to acute. The most commonly reported signs and symptoms are fever, cough, headache, myalgia, shortness of breath, nausea, vomiting, abdominal pain, and diarrhea. While pediatric hospitalizations are lower than those for adult patients, there is still inadequate data related to the general features of pediatric patients with COVID-19 in Saudi Arabia. This study aimed to identify clinical presentations, laboratory abnormalities, duration of hospitalizations, need for intensive care unit (ICU) admissions, and incidence of death and possible risk factors of mortality in pediatric patients. Methods: A retrospective study was conducted at the Maternity and Children’s Hospital in Makkah, Saudi Arabia, from March 2020 to December 2021. Pediatric patients under 18 years of age who had positive Polymerase Chain Reaction (PCR) test results for COVID-19 were included. Clinical presentations, laboratory results, medications, and any radiological abnormalities were extracted from electronic medical records and a chart review. Results: A total of 95 patients with a confirmed diagnosis of COVID-19 were included in the study. Of the patients, 50 (52.6%) were male, 64 (67.4%) were Saudi, and 31 (32.6%) were non-Saudi. The patients’ mean (SD) age was 3.71 (3.69) years. Their mean temperature rose to 38.34°C (0.8OC)O¯, and the mean duration of their fever was 2.97 (2.8) days. The most commonly observed manifestations were diarrhea, vomiting, and abdominal pain. Of the patients, 24.2% needed ICU admission, 12.6% required mechanical ventilation, 9.5% were given vasoactive agents, 2.1% required dialysis for acute kidney injury (AKI), and 5.3% passed away. The incidence of death was significant in non-Saudi patients (P ≤ .038). Conclusions: COVID-19 equally affected males and females. Most of the pediatric patients who died had co-morbidities. Fever, diarrhea, vomiting, and abdominal pain were the most prevalent symptoms.

Keywords: COVID-19 · Pediatrics · Clinical · Death

References

  1. 1.World Health Organization (WHO). Coronavirus disease (COVID-19) Situation Report – 158. Available from: https://covid19.who.int/ [cited February 28th, 2023]
  2. 2.Pascarella G, Strumia A, Piliego C, BrunoF,DelBuonoR,CostaF,Scarlata S, Agrò FE. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020 Aug;288(2):192-
  3. 3.doi: 10.1111/joim.13091. Epub 2020 May 13. PMID: 32348588; PM- CID: PMC7267177. doi:10.1111/joim.13091
  4. 4.COVID-19 Dashboard; Saudi Arabia. Available from: https://covid19.moh. gov.sa/ [cited February 28th, 2023]
  5. 5.Dong Y, Mo X, Hu Y, Qi X, Jiang F, JiangZ,TongS.EpidemiologyofCOV- ID-19Among Children in China. Pediatrics. 2020 Jun;145(6): e20200702. doi: 10.1542/peds.2020-0702. Epub 2020 Mar 16. PMID: 32179660. doi:10.1542/peds.2020-0702
  6. 6.Palmeira P, Barbuto JAM, Silva CAA, Carneiro-Sampaio M. Why is SARS- CoV-2 infection milder among children? Clinics (Sao Paulo). 2020;75: e1947. doi: 10.6061/clinics/2020/ e1947. Epub 2020 May 15. PMID: 32428111; PMCID: PMC7213663. doi:10.6061/clinics/2020/
  7. 7.CDC COVID-19 Response Team. Coronavirus Disease 2019 in Children-United States, February 12– April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422-6. Available from: https://covid19.ncdhhs. gov/?gclid=Cj0KCQjw-daUBhCIAR- IsALbkjSahoo7XHhKXDv8Hu5oZ- MXswQNOh7fSb3MuphfIRpBHO- 2N0As8I0P2waAo66EALw_wcB [cited February 18th, 2022]
  8. 8.Pereira MFB, Litvinov N, Farhat SCL, Eisencraft AP, Gibelli MABC, Carvalho WB, Fernandes VR, Fink TT, Framil JVS, Galleti KV, Fante AL, Fonseca MFM, Watanabe A, Paula CSY, Palandri GG, Leal GN, Diniz MFR, Pinho JRR, Silva CA, Marques HHS; Pediatric COVID HC-FMUSP Study Group, Rossi Junior A, Delgado AF, Andrade APM, Schvartsman C, Sabino EC, Rocha MC, Kanunfre KA, Okay TS, Carneiro-Sampaio MMS, Jorge PPD. Severe clinical spectrum with high mortality in pediatric patients with COVID-19 and multisystem inflammatory syndrome. Clinics (Sao Paulo). 2020;75: e2209. doi: 10.6061/clinics/2020/e2209. Epub 2020 Aug 19. PMID: 32844958; PM- CID: PMC7426591. doi:10.6061/clinics/2020/e2209
  9. 9.Ludvigsson JF. Systematic review of COVID-19 in children shows milder Majmaah Journal of Health Sciences ,Vol. 11, Issue 2, April - 2023, Ramadan - 1444 127 Clinical Manifestations and General Characteristics of Pediatric Patients With Covid-19: ASingle-Center Study in The Makkah Region, SaudiArabia casesandabetterprognosisthanadults. Acta Paediatr. 2020 jun;109(6):1088- 1095. doi: 10.1111/apa.15270. Epub 2020 Apr 14. PMID: 32202343; PM- CID: PMC7228328. doi:10.1111/apa.15270

Peer review

Peer reviewed by 1 reviewer, who chose to remain anonymous.

Majmaah Journal of Health Sciences · eISSN 1658-8223 · Majmaah University · open access